{"id":985935,"date":"2026-07-28T16:30:17","date_gmt":"2026-07-28T20:30:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/"},"modified":"2026-07-28T16:30:17","modified_gmt":"2026-07-28T20:30:17","slug":"pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/","title":{"rendered":"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">REDWOOD CITY, Calif., July  28, 2026  (GLOBE NEWSWIRE) &#8212; Pulmonx Corporation (Nasdaq: LUNG) (\u201cPulmonx\u201d) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Canaccord Genuity 46<sup>th<\/sup> Annual Growth Conference in Boston on Tuesday, August 11, 2026, at 1:00 PM PT \/ 4:00 PM ET.<\/p>\n<p align=\"justify\">A live and archived webcast of the fireside chat will be available on \u201cInvestors\u201d section of the Pulmonx website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GjwFMUAimC0vTc4lXvQW6CzBW7c57tRnbBzdzAjokbUNfxv5zb_7xDX-APCA3e4d6qe0oK5NUVQvM2OHJ5HPWZeWRwVZZvoFJoZbiKhBsn60_EGxovvM7rnXpWktGYo9\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.pulmonx.com\/<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Pulmonx Corporation<br \/><\/strong>Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD).\u202fPulmonx\u2019s\u202fZephyr<sup>\u00ae<\/sup> Endobronchial Valve,\u202fChartis<sup>\u00ae<\/sup> Pulmonary Assessment System, LungTraX<sup>\u00ae<\/sup>\u202fPlatform, and\u202fStratX\u00ae Lung Analysis Reports are designed to assess and treat patients with severe emphysema\/COPD who despite medical management are still profoundly symptomatic. Pulmonx received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) to commercialize the Zephyr<sup>\u00ae<\/sup> Endobronchial Valve following its designation as a \u201cbreakthrough device.\u201d The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option\u202ffor improving breathing,\u202factivity\u202fand quality of life in patients with severe emphysema. For more information on\u202fthe Zephyr\u202fValves and the company, please visit\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=saNfBioAqV82sn2Oiyz8dhczt-3RwAigPJX9gSMAumT9MQpfCr6SO2mHrkOVo9GaPeuJ4E4c88sY_rVgkT1niJJGZ-be9WAtzfSjfomxfP3vM1fWMCknrQujswG9MDErSVGxtcx2nvyZbkahphthEmL7FOjO-h_J_vf3pK2AGlaTH5lSqn17fU5xaAdqeHqsLh_tnencHr0LnjzJb5i_F2J2-nYlu0hN5f_krTYVHarfllA3Yut9PZIk8SLQRwbJ7haWop8F1L41ANszzSsx0-0n58BBCOLyGVYaj0PZwnFe3ivI4OInxgbxO9qDzGBc9lx9IOATb8MRaTPZgXVTvyY3AnOzhVa1A5s3wn2b0vey56FlFR9xv85No1jVvJjHl2__VjT-UGKVfuDptuTzzotLlzJLanmqFwahQ9PmD0yg_CWJyAmmKHAflYc_Hfi_T1J4nJIUQskSTqvx8g9AQB1Aw9m81F5ggk21n7-mTEZfRo7bxbObFV2olxiRDas30mN3RHYv7Il_ld4XzhGhWQFOHdke1E5jAMN9_8-WSK3Ovu28mvKoeiyY6YUGjZpj\" rel=\"nofollow\" target=\"_blank\">www.Pulmonx.com<\/a>.\u202f\u00a0<br \/>\u202f\u00a0<br \/>Pulmonx<sup>\u00ae<\/sup>,\u202fAeriSeal<sup>\u00ae<\/sup>,\u202fChartis<sup>\u00ae<\/sup>, LungTraX<sup>\u00ae<\/sup>,\u202fStratX<sup>\u00ae<\/sup>, and Zephyr<sup>\u00ae<\/sup> are registered\u202ftrademarks of Pulmonx Corporation.\u202f\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Contact<\/strong><br \/>\n        <br \/>Brian Johnston<br \/>Gilmartin Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fZMQepsDqFsRoqP4e8l1wVya7nuPGYVq7u9IyI5kRpJFQWkh2ps66wbP7q0TgGRZHNwP7jCyC5yOkzWAPXu_83i0FAht1RIawuO1DANSu_0=\" rel=\"nofollow\" target=\"_blank\">investors@pulmonx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTYwZTFmYjYtM2NhMy00NTNjLTg3MmMtN2UxNjg5MDM3YzRjLTEyMDYxNDItMjAyNi0wNy0yOC1lbg==\/tiny\/Pulmonx-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) &#8212; Pulmonx Corporation (Nasdaq: LUNG) (\u201cPulmonx\u201d) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, August 11, 2026, at 1:00 PM PT \/ 4:00 PM ET. A live and archived webcast of the fireside chat will be available on \u201cInvestors\u201d section of the Pulmonx website at https:\/\/investors.pulmonx.com\/. About Pulmonx CorporationPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD).\u202fPulmonx\u2019s\u202fZephyr\u00ae Endobronchial Valve,\u202fChartis\u00ae Pulmonary Assessment System, LungTraX\u00ae\u202fPlatform, and\u202fStratX\u00ae Lung Analysis Reports are designed to assess and treat patients with severe emphysema\/COPD &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-985935","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) &#8212; Pulmonx Corporation (Nasdaq: LUNG) (\u201cPulmonx\u201d) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, August 11, 2026, at 1:00 PM PT \/ 4:00 PM ET. A live and archived webcast of the fireside chat will be available on \u201cInvestors\u201d section of the Pulmonx website at https:\/\/investors.pulmonx.com\/. About Pulmonx CorporationPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD).\u202fPulmonx\u2019s\u202fZephyr\u00ae Endobronchial Valve,\u202fChartis\u00ae Pulmonary Assessment System, LungTraX\u00ae\u202fPlatform, and\u202fStratX\u00ae Lung Analysis Reports are designed to assess and treat patients with severe emphysema\/COPD &hellip; Continue reading &quot;Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-28T20:30:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference\",\"datePublished\":\"2026-07-28T20:30:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/\"},\"wordCount\":242,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/\",\"name\":\"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=\",\"datePublished\":\"2026-07-28T20:30:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk","og_description":"REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) &#8212; Pulmonx Corporation (Nasdaq: LUNG) (\u201cPulmonx\u201d) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, August 11, 2026, at 1:00 PM PT \/ 4:00 PM ET. A live and archived webcast of the fireside chat will be available on \u201cInvestors\u201d section of the Pulmonx website at https:\/\/investors.pulmonx.com\/. About Pulmonx CorporationPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD).\u202fPulmonx\u2019s\u202fZephyr\u00ae Endobronchial Valve,\u202fChartis\u00ae Pulmonary Assessment System, LungTraX\u00ae\u202fPlatform, and\u202fStratX\u00ae Lung Analysis Reports are designed to assess and treat patients with severe emphysema\/COPD &hellip; Continue reading \"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-28T20:30:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference","datePublished":"2026-07-28T20:30:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/"},"wordCount":242,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/","name":"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=","datePublished":"2026-07-28T20:30:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTM5MiM3NzQ3MDMxIzIxOTQ1ODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pulmonx-to-present-at-the-canaccord-genuity-46th-annual-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/985935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=985935"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/985935\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=985935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=985935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=985935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}